• Tue, July 26, 2022
Do Kim Maintained (ABCL) at Buy with Increased Target to $22 on, Jul 26th, 2022
Do Kim of Piper Sandler, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $21 to $22 on, Jul 26th, 2022.
Do has made no other calls on ABCL in the last 4 months.
There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Do's Rating of Hold.
This is the rating of the analyst that currently disagrees with Do
- Puneet Souda of "SVB Leerink" Maintained at Buy with Decreased Target to $14 on, Wednesday, May 11th, 2022
Like: 👍
